Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma-Reference-Cited by-同舟云学术

Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma

Published:2014-05 Issue:1 Volume:20 Page:59-65
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Minami Takafumi,Minami Tomoko,Shimizu Nobutaka,Yamamoto Yutaka,De Velasco Marco,Nozawa Masahiro,Yoshimura Kazuhiro,Harashima Nanae,Harada Mamoru,Uemura Hirotsugu

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference32 articles.

1. Renal cell carcinoma guideline;Ljungberg;Eur Urol,2007

2. Tumor vaccines in renal cell carcinoma;Uemura;World J Urol,2008

3. Induction of antigen specific cellular immunity by vaccination with peptides from MN/CA IX in renal cell carcinoma;Shimizu;Oncol Rep,2003

4. A phase I trial of vaccination of CA9-derived peptides for HLA-A24-positive patients with cytokine-refractory metastatic renal cell carcinoma;Uemura;Clin Cancer Res,2006

5. Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma;Yoshimura;Br J Cancer,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T-cell responses and combined immunotherapy against human carbonic anhydrase 9-expressing mouse renal cell carcinoma;Cancer Immunology, Immunotherapy;2021-06-23

2. Basic Parameters of Blood Count, Serum Sodium, and Creatinine as Prognostic Factors for Renal Cell Carcinoma at Five-Year Follow-Up;Medical Science Monitor;2018-06-09

3. Present status and future perspective of peptide-based vaccine therapy for urological cancer;Cancer Science;2018-02-15

4. Hypoxia-inducing factor (HIF)-1α-derived peptide capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma;International Immunopharmacology;2017-03

5. Effective induction of cytotoxic T cells recognizing an epitope peptide derived from hypoxia-inducible protein 2 (HIG2) in patients with metastatic renal cell carcinoma;Cancer Immunology, Immunotherapy;2016-10-18